resiquimod has been researched along with mannose in 1 studies
| Studies (resiquimod) | Trials (resiquimod) | Recent Studies (post-2010) (resiquimod) | Studies (mannose) | Trials (mannose) | Recent Studies (post-2010) (mannose) |
|---|---|---|---|---|---|
| 465 | 14 | 318 | 9,698 | 41 | 2,248 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, W; Jia, D; Li, G; Li, J; Liu, R; Lu, X; Lu, Y; Lv, M; Wang, F; Wang, R; Wei, J; Yuan, F; Zhu, W | 1 |
1 other study(ies) available for resiquimod and mannose
| Article | Year |
|---|---|
Targeted co-delivery of resiquimod and a SIRPĪ± variant by liposomes to activate macrophage immune responses for tumor immunotherapy.
Topics: CD47 Antigen; Humans; Immunotherapy; Liposomes; Macrophages; Mannose; Neoplasms; Phagocytosis; Tumor Microenvironment | 2023 |